What is Arvinas's total equity?

Arvinas (ARVN) reported total equity of $386.8M in Q1 2026.

How has Arvinas's total equity changed year-over-year?

Arvinas's total equity decreased by 41.4% year-over-year, from $660.1M to $386.8M.

What is the long-term trend for Arvinas's total equity?

Over 5 years (2020 to 2025), Arvinas's total equity has grown at a -7.5% compound annual growth rate (CAGR), from $642.2M to $433.9M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Arvinas ARVN Total Equity

Total Equity at other companies

Nurix Therapeutics, Inc.NRIX

$480.89M0.0%

Kymera TherapeuticsKYMR

$1.54B+95.8%

Monte Rosa Therapeutics, Inc.GLUE

$521.92M+89.7%

Relmada Therapeutics, Inc.RLMD

$218.73M+875%

Nuvectis Pharma, Inc.NVCT

$14.22M-32.1%

ArriVent BioPharma, Inc.AVBP

$323.98M+60.0%

Other financials

Income statement

See full

Revenue$15.6M-91.7%

Operating income-$63.8M-189%

Net income-$57.6M-169%

EPS (diluted)-$0.90-179%

Balance sheet

See full

Cash & equivalents$87.3M+7.8%

Total debt$8.6M-19.6%

Total assets$647.5M-35.3%

Cash flow

See full

Operating cash flow-$69.2M+22.2%

CapEx$1.3M+225%

Free cash flow-$70.5M+21.1%

Valuation

See full

Market cap$518.11M-4.6%

Enterprise value$439.41M-7.1%

P/S5.8×+4.5×

Profitability

See full

Operating margin-283.8%-310pp

Net margin-247.5%-260pp

FCF margin-287.4%—

Returns & leverage

See full

Return on equity-42.3%-53.5pp

Debt / equity0×0.0×

Current ratio5.4×+0.9×

Where this comes from

Reported directly by Arvinas in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Arvinas’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arvinas's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arvinas's total equity?: Arvinas (ARVN) reported total equity of $386.8M in Q1 2026.
How has Arvinas's total equity changed year-over-year?: Arvinas's total equity decreased by 41.4% year-over-year, from $660.1M to $386.8M.
What is the long-term trend for Arvinas's total equity?: Over 5 years (2020 to 2025), Arvinas's total equity has grown at a -7.5% compound annual growth rate (CAGR), from $642.2M to $433.9M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.